MicroDep Clinical Trial - Macquarie University

Recruitment is now open for a clinical trial investigating psychedelic microdosing as a treatment for depression. Researchers at Macquarie University are recruiting participants for a clinical trial investigating microdosing with psilocybin as a treatment for depression.
This trial uses very low doses, not expected to lead to alterations in consciousness.
Participants will take part in a six week intervention, with two doses per week.
Participants are monitored by a psychiatrist throughout the intervention.

The MicroDep Trial was featured on 10 News

MicroDep Trial: Investigating low doses of psilocybin for moderate depression - 10 News 10 News Australia reports on the MicroDep Trial at Macquarie University, Sydney. This trial will investigate whether low doses of psilocybin can treat moder...

The MicroDep Trial is now recruiting participants with moderate depression in Sydney. Here's some information about eligibility.
You can find out more by contacting us at [email protected]
Or if you would like to enrol, you can complete an initial screener at https://redcap.mq.edu.au/surveys/?s=XNXMCTXR4H&source=fbpage